Current treatments focus on maintaining glycemic control through insulin replacement therapy, continuous glucose monitoring, dietary management, and physical activity to prevent complications and maintain quality of life
Who Should Consider IGF-1 LR3 Therapy
Methionine and choline enter systemic circulation without immediately reaching the liver, where their lipotropic effects occur
Compared with standard glutathione (500 mg), LipoMicel at a lower dose (300 mg) increased iAUC and C max by ~2.49-fold and ~2.43-fold, respectively, and when dose-normalized (to a 300 mg equivalent), incremental systemic exposure and peak levels were up to ~4-fold higher, supporting greater absorption per unit dose. The findings indicate LipoMicel is a promising delivery method for oral glutathione, though the researchers added larger, long-term studies are still needed
Its to arm broker judgment with the data that makes it defensible, specific, and actionable